nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.201	0.268	CbGbCtD
Penicillamine—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.195	0.26	CbGbCtD
Penicillamine—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.177	0.236	CbGbCtD
Penicillamine—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.177	0.236	CbGbCtD
Penicillamine—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.00035	0.0014	CcSEcCtD
Penicillamine—Pancreatitis—Lamivudine—acquired immunodeficiency syndrome	0.00035	0.0014	CcSEcCtD
Penicillamine—Urinary tract disorder—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00139	CcSEcCtD
Penicillamine—Urethral disorder—Efavirenz—acquired immunodeficiency syndrome	0.000344	0.00138	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Didanosine—acquired immunodeficiency syndrome	0.000343	0.00137	CcSEcCtD
Penicillamine—Arthralgia—Nelfinavir—acquired immunodeficiency syndrome	0.000342	0.00137	CcSEcCtD
Penicillamine—Arthralgia—Stavudine—acquired immunodeficiency syndrome	0.000341	0.00136	CcSEcCtD
Penicillamine—Dysgeusia—Zidovudine—acquired immunodeficiency syndrome	0.000341	0.00136	CcSEcCtD
Penicillamine—Anxiety—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.00136	CcSEcCtD
Penicillamine—Renal failure—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00136	CcSEcCtD
Penicillamine—Anxiety—Stavudine—acquired immunodeficiency syndrome	0.00034	0.00136	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.00034	0.00136	CcSEcCtD
Penicillamine—Neuropathy peripheral—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.00136	CcSEcCtD
Penicillamine—Pancytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.00136	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.000339	0.00136	CcSEcCtD
Penicillamine—Stomatitis—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00135	CcSEcCtD
Penicillamine—Arthralgia—Abacavir—acquired immunodeficiency syndrome	0.000336	0.00134	CcSEcCtD
Penicillamine—Anxiety—Abacavir—acquired immunodeficiency syndrome	0.000335	0.00134	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000333	0.00134	CcSEcCtD
Penicillamine—Thrombocytopenia—Nevirapine—acquired immunodeficiency syndrome	0.000331	0.00133	CcSEcCtD
Penicillamine—Haematuria—Ritonavir—acquired immunodeficiency syndrome	0.00033	0.00132	CcSEcCtD
Penicillamine—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Penicillamine—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000329	0.00132	CcSEcCtD
Penicillamine—Renal failure—Saquinavir—acquired immunodeficiency syndrome	0.000328	0.00131	CcSEcCtD
Penicillamine—Tinnitus—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.00131	CcSEcCtD
Penicillamine—Hepatobiliary disease—Ritonavir—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Penicillamine—Decreased appetite—Didanosine—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Penicillamine—Neuropathy peripheral—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00131	CcSEcCtD
Penicillamine—Stomatitis—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.0013	CcSEcCtD
Penicillamine—Anorexia—Nevirapine—acquired immunodeficiency syndrome	0.000323	0.00129	CcSEcCtD
Penicillamine—Anaemia—Zidovudine—acquired immunodeficiency syndrome	0.000322	0.00129	CcSEcCtD
Penicillamine—Thrombocytopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000321	0.00128	CcSEcCtD
Penicillamine—Thrombocytopenia—Stavudine—acquired immunodeficiency syndrome	0.00032	0.00128	CcSEcCtD
Penicillamine—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00128	CcSEcCtD
Penicillamine—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000318	0.00127	CcSEcCtD
Penicillamine—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Penicillamine—Dysgeusia—Indinavir—acquired immunodeficiency syndrome	0.000317	0.00127	CcSEcCtD
Penicillamine—Thrombocytopenia—Abacavir—acquired immunodeficiency syndrome	0.000315	0.00126	CcSEcCtD
Penicillamine—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.00126	CcSEcCtD
Penicillamine—Tinnitus—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00125	CcSEcCtD
Penicillamine—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000313	0.00125	CcSEcCtD
Penicillamine—Renal failure—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Penicillamine—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Penicillamine—Haemoglobin—Ritonavir—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Penicillamine—Neuropathy peripheral—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Penicillamine—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000312	0.00125	CcSEcCtD
Penicillamine—Anorexia—Stavudine—acquired immunodeficiency syndrome	0.000311	0.00125	CcSEcCtD
Penicillamine—Haemorrhage—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00124	CcSEcCtD
Penicillamine—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Penicillamine—Stomatitis—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00124	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	0.000308	0.00123	CcSEcCtD
Penicillamine—Urinary tract disorder—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Penicillamine—Anorexia—Abacavir—acquired immunodeficiency syndrome	0.000307	0.00123	CcSEcCtD
Penicillamine—Urethral disorder—Ritonavir—acquired immunodeficiency syndrome	0.000305	0.00122	CcSEcCtD
Penicillamine—Haemoglobin—Saquinavir—acquired immunodeficiency syndrome	0.000301	0.0012	CcSEcCtD
Penicillamine—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.0012	CcSEcCtD
Penicillamine—Dysgeusia—Efavirenz—acquired immunodeficiency syndrome	0.000299	0.0012	CcSEcCtD
Penicillamine—Haemorrhage—Saquinavir—acquired immunodeficiency syndrome	0.000299	0.0012	CcSEcCtD
Penicillamine—Anaemia—Indinavir—acquired immunodeficiency syndrome	0.000299	0.0012	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	0.000299	0.0012	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Penicillamine—Body temperature increased—Didanosine—acquired immunodeficiency syndrome	0.000298	0.00119	CcSEcCtD
Penicillamine—Agitation—Indinavir—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Penicillamine—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Penicillamine—Agranulocytosis—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00119	CcSEcCtD
Penicillamine—Arthralgia—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00119	CcSEcCtD
Penicillamine—Urinary tract disorder—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00118	CcSEcCtD
Penicillamine—Anxiety—Zidovudine—acquired immunodeficiency syndrome	0.000295	0.00118	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Penicillamine—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	0.000294	0.00118	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Penicillamine—Urethral disorder—Saquinavir—acquired immunodeficiency syndrome	0.000293	0.00117	CcSEcCtD
Penicillamine—Tinnitus—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00116	CcSEcCtD
Penicillamine—Dysgeusia—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.00115	CcSEcCtD
Penicillamine—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	0.000285	0.00114	CcSEcCtD
Penicillamine—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	0.000284	0.00114	CcSEcCtD
Penicillamine—Anaemia—Efavirenz—acquired immunodeficiency syndrome	0.000283	0.00113	CcSEcCtD
Penicillamine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Penicillamine—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00113	CcSEcCtD
Penicillamine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000281	0.00113	CcSEcCtD
Penicillamine—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	0.00028	0.00112	CcSEcCtD
Penicillamine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00112	CcSEcCtD
Penicillamine—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000278	0.00111	CcSEcCtD
Penicillamine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000277	0.00111	CcSEcCtD
Penicillamine—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.0011	CcSEcCtD
Penicillamine—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000276	0.0011	CcSEcCtD
Penicillamine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000275	0.0011	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000274	0.0011	CcSEcCtD
Penicillamine—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00109	CcSEcCtD
Penicillamine—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00109	CcSEcCtD
Penicillamine—Anorexia—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.00108	CcSEcCtD
Penicillamine—Anaemia—Delavirdine—acquired immunodeficiency syndrome	0.00027	0.00108	CcSEcCtD
Penicillamine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Penicillamine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000269	0.00108	CcSEcCtD
Penicillamine—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000268	0.00107	CcSEcCtD
Penicillamine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00106	CcSEcCtD
Penicillamine—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00106	CcSEcCtD
Penicillamine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000263	0.00105	CcSEcCtD
Penicillamine—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Penicillamine—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00105	CcSEcCtD
Penicillamine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Penicillamine—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Penicillamine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Penicillamine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Penicillamine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00026	0.00104	CcSEcCtD
Penicillamine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Penicillamine—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Penicillamine—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000259	0.00104	CcSEcCtD
Penicillamine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Penicillamine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000258	0.00103	CcSEcCtD
Penicillamine—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000257	0.00103	CcSEcCtD
Penicillamine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000256	0.00102	CcSEcCtD
Penicillamine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00102	CcSEcCtD
Penicillamine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00102	CcSEcCtD
Penicillamine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00101	CcSEcCtD
Penicillamine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00101	CcSEcCtD
Penicillamine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.00025	0.001	CcSEcCtD
Penicillamine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000249	0.000998	CcSEcCtD
Penicillamine—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000997	CcSEcCtD
Penicillamine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000249	0.000996	CcSEcCtD
Penicillamine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000248	0.000994	CcSEcCtD
Penicillamine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000247	0.000989	CcSEcCtD
Penicillamine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000245	0.000982	CcSEcCtD
Penicillamine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000244	0.000978	CcSEcCtD
Penicillamine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.000974	CcSEcCtD
Penicillamine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.000971	CcSEcCtD
Penicillamine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000242	0.00097	CcSEcCtD
Penicillamine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000241	0.000967	CcSEcCtD
Penicillamine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000241	0.000964	CcSEcCtD
Penicillamine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000241	0.000964	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000241	0.000964	CcSEcCtD
Penicillamine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000239	0.000958	CcSEcCtD
Penicillamine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.000958	CcSEcCtD
Penicillamine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.000952	CcSEcCtD
Penicillamine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000237	0.00095	CcSEcCtD
Penicillamine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000237	0.00095	CcSEcCtD
Penicillamine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000237	0.000949	CcSEcCtD
Penicillamine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000234	0.000936	CcSEcCtD
Penicillamine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.000933	CcSEcCtD
Penicillamine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000929	CcSEcCtD
Penicillamine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000232	0.000927	CcSEcCtD
Penicillamine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000922	CcSEcCtD
Penicillamine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00023	0.000919	CcSEcCtD
Penicillamine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.00023	0.000919	CcSEcCtD
Penicillamine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000919	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000229	0.000916	CcSEcCtD
Penicillamine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.000911	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.00091	CcSEcCtD
Penicillamine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000226	0.000903	CcSEcCtD
Penicillamine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000899	CcSEcCtD
Penicillamine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000224	0.000898	CcSEcCtD
Penicillamine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000224	0.000895	CcSEcCtD
Penicillamine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000224	0.000895	CcSEcCtD
Penicillamine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000222	0.00089	CcSEcCtD
Penicillamine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000222	0.000888	CcSEcCtD
Penicillamine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000885	CcSEcCtD
Penicillamine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00022	0.000882	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000882	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000871	CcSEcCtD
Penicillamine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000217	0.000869	CcSEcCtD
Penicillamine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000866	CcSEcCtD
Penicillamine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000215	0.000862	CcSEcCtD
Penicillamine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000859	CcSEcCtD
Penicillamine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000213	0.000854	CcSEcCtD
Penicillamine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000213	0.000854	CcSEcCtD
Penicillamine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000847	CcSEcCtD
Penicillamine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000844	CcSEcCtD
Penicillamine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000843	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000841	CcSEcCtD
Penicillamine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00021	0.00084	CcSEcCtD
Penicillamine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000836	CcSEcCtD
Penicillamine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000208	0.000834	CcSEcCtD
Penicillamine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000833	CcSEcCtD
Penicillamine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000832	CcSEcCtD
Penicillamine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000831	CcSEcCtD
Penicillamine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000207	0.000827	CcSEcCtD
Penicillamine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000206	0.000827	CcSEcCtD
Penicillamine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000827	CcSEcCtD
Penicillamine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000206	0.000825	CcSEcCtD
Penicillamine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000206	0.000824	CcSEcCtD
Penicillamine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000205	0.00082	CcSEcCtD
Penicillamine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000203	0.000813	CcSEcCtD
Penicillamine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000203	0.000812	CcSEcCtD
Penicillamine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000811	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000805	CcSEcCtD
Penicillamine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000201	0.000805	CcSEcCtD
Penicillamine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000795	CcSEcCtD
Penicillamine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000794	CcSEcCtD
Penicillamine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.00079	CcSEcCtD
Penicillamine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000789	CcSEcCtD
Penicillamine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.00078	CcSEcCtD
Penicillamine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000779	CcSEcCtD
Penicillamine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.000778	CcSEcCtD
Penicillamine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000194	0.000777	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000775	CcSEcCtD
Penicillamine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000774	CcSEcCtD
Penicillamine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000769	CcSEcCtD
Penicillamine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000191	0.000766	CcSEcCtD
Penicillamine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.00076	CcSEcCtD
Penicillamine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000756	CcSEcCtD
Penicillamine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.00074	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.00074	CcSEcCtD
Penicillamine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000736	CcSEcCtD
Penicillamine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000724	CcSEcCtD
Penicillamine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000723	CcSEcCtD
Penicillamine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000717	CcSEcCtD
Penicillamine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000716	CcSEcCtD
Penicillamine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000706	CcSEcCtD
Penicillamine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000704	CcSEcCtD
Penicillamine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000702	CcSEcCtD
Penicillamine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000699	CcSEcCtD
Penicillamine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000684	CcSEcCtD
Penicillamine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000676	CcSEcCtD
Penicillamine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000675	CcSEcCtD
Penicillamine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000673	CcSEcCtD
Penicillamine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000672	CcSEcCtD
Penicillamine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000667	CcSEcCtD
Penicillamine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000166	0.000666	CcSEcCtD
Penicillamine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000654	CcSEcCtD
Penicillamine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000651	CcSEcCtD
Penicillamine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000645	CcSEcCtD
Penicillamine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000642	CcSEcCtD
Penicillamine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000635	CcSEcCtD
Penicillamine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.00063	CcSEcCtD
Penicillamine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000629	CcSEcCtD
Penicillamine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000628	CcSEcCtD
Penicillamine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000627	CcSEcCtD
Penicillamine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000608	CcSEcCtD
Penicillamine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000605	CcSEcCtD
Penicillamine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000603	CcSEcCtD
Penicillamine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000602	CcSEcCtD
Penicillamine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000598	CcSEcCtD
Penicillamine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000594	CcSEcCtD
Penicillamine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000582	CcSEcCtD
Penicillamine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000568	CcSEcCtD
Penicillamine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000562	CcSEcCtD
Penicillamine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000557	CcSEcCtD
Penicillamine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000557	CcSEcCtD
Penicillamine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000555	CcSEcCtD
Penicillamine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000541	CcSEcCtD
Penicillamine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000537	CcSEcCtD
Penicillamine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000536	CcSEcCtD
Penicillamine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000525	CcSEcCtD
Penicillamine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000516	CcSEcCtD
Penicillamine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000512	CcSEcCtD
Penicillamine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000511	CcSEcCtD
Penicillamine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000505	CcSEcCtD
Penicillamine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000482	CcSEcCtD
